We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021

By LabMedica International staff writers
Posted on 29 Sep 2021
Print article
Image: Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021 (Photo courtesy of Abbott Diagnostics)
Image: Abbott Demonstrates Core Diagnostics Solutions Consisting of Innovative Systems, Automation and Informatics at AACC 2021 (Photo courtesy of Abbott Diagnostics)

Abbott Diagnostics (Lake Bluff, IL, USA) displayed its leading-edge technology at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo with demonstrations of its innovative systems, automation and informatics.

Abbott’s innovative solutions on display at AACC 2021 included Alinity Systems, total laboratory automation and AliniQ Informatics and Professional Services. The company also showed how labs can create an agile strategy with The Abbott Transformation System and the invaluable answers that it placed in the hands of doctors, clinicians and caregivers at the Point of Care.

Abbott’s Alinity family comprises next-generation systems across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening and molecular diagnostics. On display at the event were the Alinity ci-series integrated clinical chemistry & immunoassay system, Alinity c clinical chemistry system, ALINITY I immunoassay system, and the Alinity m fully integrated, automated, high-throughput molecular diagnostics analyzer. Each Alinity system includes a number of features to help institutions, clinicians and laboratorians better navigate through a pressure-packed health care environment. Designed with universal, intuitive interfaces as well as common software and hardware, Abbott's Alinity systems have the ability to work together, providing greater capacity and simplifying the user experience. Several of the platforms are designed to run more tests in less space, generate test results faster and minimize human errors.

At AACC 2021, Abbott also highlighted its synergistic suite of automation and high volume end-to-end solutions that deliver seamless productivity across the entire laboratory. This included the ACCELERATOR a3600 total laboratory automation system that provides the power and flexibility to meet the needs of the laboratory, both today and in the future. Combined with informatics and lean principles, the ACCELERATOR a3600 maximizes efficiency by providing consistent, predictable sample management and helps improve patient care by minimizing opportunities for error.

Additionally, Abbott demonstrated how its AlinIQ suite of professional services can help labs uncover intelligent insights from their laboratory data and discover greater operational productivity with existing resources. For instance, Abbott’s The AlinIQ Always On services deliver predictive alerts to labs, enabling the detection and prevention of instrument downtime up to three days in advance. The AlinIQ AMS (Analyzer Management System) provides labs and hospital networks the ability to integrate different software systems into a single standardized platform to optimize sample processing time, workflow efficiency and quality results. Similarly, the AlinIQ BIS (Business Intelligence System) provides the tools to optimize throughput and capacity of existing systems to help labs absorb volume increases without additional budget. By delivering intelligent insights, AlinIQ BIS helps labs improve operations and operational expense performance and communicate the lab's value to the broader health care organization. The AlinIQ IMS (Inventory Management System), which combines innovative RFID technology and streamlined process consulting, allows labs to get ahead of operational needs, helping avoid shortages of critical items, reduce waste and time taken for manual processes.

Related Links:
Abbott Diagnostics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more